Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis

CompletedNot a drug-phase studyRelapsing MSNCT01122056

What it found

No results found

We found no results in the registry or in papers.

This trial finished 14 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Physical exercise training

What it measured

Main measures

  • Multiple Sclerosis Fatigue

    Fatigue
  • Quality of Life

    Quality of life (reported by participants)
  • Injection site visual analog scale (0-10)

    Safety

Who could take part

Relapsing MS · 18 to 65

Show the full criteria

Inclusion criteria

* Recent diagnosis of relapsing remitting multiple sclerosis on treatment with b1b-interferon disease modifying treatment

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this study is to investigate the effects and tolerability of exercise on side effects of injectable disease modifying treatments in multiple sclerosis. The investigators main hypothesis is that controlled exercise is safe and can be well tolerated in patients with multiple sclerosis and it can improve disease modifying treatment related side effects such as fatigue.

Loading reviews and guidelines…

History

    1. Started

      May 2010

    2. Main results due

      Jun 2012

    3. Finished

      Jun 2012

    Assembled by software from public sources.